Race Can Affect Decision About Lung Cancer Treatment

Lung Cancer and Race

Race may play a role in whether a patient accepts surgical treatment for lung cancer. A study in the November issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), found that blacks with lung cancer declined surgery at a higher rate than whites, leading researchers to believe that blacks may be misinformed about the effects of lung cancer surgery.

Advertisement

"Surgery for early stage non-small cell lung cancer is standard treatment and is likely curative. Yet, fewer blacks than whites undergo surgery for the disease, leading to a higher mortality rate among blacks with lung cancer," said Bruno DiGiovine MD, FCCP, Henry Ford Health System, Detroit, MI. "Identifying and addressing the underlying reason for this discrepancy in surgical rates may, ultimately, lead to greater rates of surgical acceptance and decreased mortality rates among blacks with lung cancer."

Researchers from Henry Ford Health System speculated that the discrepancy in lung cancer surgical rates between blacks and whites may be a result of racial bias by the physician, a high rate of comorbidities among blacks, or a low rate of surgical acceptance among blacks. To assess these possible reasons, researchers compared the rates at which blacks and whites were offered and accepted surgery for stages I and II non-small cell lung cancer. Of the 97 blacks and 184 whites in the study, 74 percent of whites underwent surgical resection, compared with 58 percent of blacks. Within the two groups, 79 percent of whites was offered surgery, compared with 70 percent of blacks. Of those patients offered surgical resection, blacks were over three times more likely to decline surgery, with 18 percent of blacks and 5 percent of whites declining surgery.

"Knowing blacks decline surgery at a higher rate than whites is the first step to decreasing lung cancer mortality among this population. We must now identify why so many blacks decline lung cancer surgery," said Dr. DiGiovine. "Prior research has shown that blacks may be misinformed about the risks of surgery, as they are more likely than whites to believe that lung cancer will spread if exposed to air during operation. This misinformation may contribute to the low rate of lung cancer surgery acceptance among blacks, however, more research is needed in this area."

Related Terms

A low-dose CT Scan, screening, which is not recommended for everyone, awareness and lung cancer screening coverage are four crucial topics that everyone need to know about lung cancer. This story is reported by the American Lung Cancer Association.

Compassion is in short supply in our society these days. Several days ago I asked the members of Lung Cancer Awareness group on Facebook to share stories of compassion to share with eMaxHealth readers. One of the members named Tanya Cohoon shared this uplifting and inspiring episode form her life that happened few weeks ago.

The Food and Drug Administration (FDA) approved a new combination drug therapy after cohort studies found the addition of immunotherapy drug Keytruda (pembrolizumab) to standard chemotherapy treatments of pemetrexed and carboplatin for patients with metastatic or advanced nonsquamous non-small cell lung cancer (NSCLC) sped up response time to treatment and halted cancer progression over use of chemotherapy alone.

There seems to be the belief among many e-cigarette smokers that they are not at an increased risk for cancer as are people who smoke regular cigarettes. However researchers say that in e-cigarettes operating at high power cancer causing benzene is present.

Once there is a suspicion of lung cancer, the next step is usually a biopsy to confirm the diagnosis. This is a common test, but does not come without risk. Scientists may have found a less invasive way to confirm lung cancer.